• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Tuesday, November 17, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Oceania Australia New Zealand

Pharmac Says It Can’t Progress Trikafta

by Theinsightpost
September 15, 2022
in New Zealand
0 0
0
Pharmac Says It Can’t Progress Trikafta


Friday, 16 September 2022, 10:37 am
Press Release: Cystic Fibrosis New Zealand

Yet again, Pharmac has raised the hopes of Kiwis with
cystic fibrosis only to shatter them.

After months of
what appeared to be encouraging progress, Cystic Fibrosis NZ
(CFNZ) has been advised by Pharmac that, following its
September medicines’ ranking process, Trikafta has not
moved up the Options for Investment (OFI) List.

The
outcome of this is that Pharmac is not in a position
to move forward with funding Trikafta at this time,

and that funding is unlikely to occur without
changes to the information at hand.

Lisa
Burns, Chief Executive for CFNZ says “We are shocked and
outraged at this decision from Pharmac. This highlights our
significant concerns about what is going on within Pharmac,
their processes, decision criteria, and how these decisions
are being communicated. We have been left confused and
don’t have the words to convey our deep disappointment for
our CF community.”

In August 2022, Pharmac released
the record of advice from its Pharmacology and Therapeutics
Advisory Committee (PTAC) and published a summary of its
Technology Assessment Report (TAR) containing its assessment
of the cost-effectiveness of Trikafta.

As part of that
release, Pharmac acknowledged the major benefits that
Trikafta offers, not just to the health system but an
extension to life expectancy and quality of life, estimating
that Trikafta would provide benefits equivalent to
27 more years at full health when compared to
current treatments
.

Pharmac also stated that
it had already re-ranked Trikafta on its Options for
Investment (OFI) List and was continuing commercial
discussions with Trikafta’s supplier, Vertex, to try and
reach an agreement that would enable funding.

However,
Pharmac has now advised CFNZ that Trikafta was re-ranked
again in September, but it has not moved high enough up the
OFI List for it to progress to funding at this time. Pharmac
has advised CFNZ that changes would be needed to one or more
of the factors for consideration before Trikafta could be
re-ranked again and have the chance to move further up the
OFI List.

These have been outlined as:

  1. More
    information that could change Pharmac’s Factors for
    Consideration
  2. A change in the price offered by
    Vertex
  3. Additional budget uplift.

Lisa
said “The failure of Trikafta to move up the OFI List to
progress funding makes it very clear that the Pharmac
process does not work for modern medicines. Despite all
available evidence, assessments and reassessments,
validation by their Clinical Experts, we’re going round in
circles with unnecessary delays due to poor process, and
decision making.”

“We are utterly thrown by
Pharmac’s decision not to prioritise funding Trikafta. It
defies logic that a medicine with such positive impact
doesn’t make it up the ranking list for funding. The
current average life-expectancy in New Zealand is 31 yet
Trikafta could give Kiwis with CF an additional 27 years,
and quality of life. It doesn’t make any
sense.”

Pharmac stated in its August release that
they don’t just look at how much, in dollar terms a
medicine costs, that they also consider the health benefits
to the person taking the medicine and what the benefits
would be to the healthcare system. This is inconsistent with
the decision advised to CFNZ where cost appears to be a
barrier in moving the application forward.

“Trikafta
is now available in more than 30 countries around the world.
Pharmac has had access to the same information and evidence,
in fact they’ve had the benefit of all the additional
worldwide clinical data provided by Vertex, so are they
implying that all those countries got it wrong?” said
Lisa.

Trikafta would be a highly cost-effective
investment. Independent work commissioned by CFNZ for
2019/20, calculated the approximate annual social, economic,
and financial cost of CF to be $116m which
was shared with Pharmac. The estimated annual cost to
fund Trikafta would be significantly less than
$60m
.

Pharmac has advised CFNZ that “the
door is not closed” and that “Trikafta is a medicine we
want to fund”. But, even if changes can be made to enable
Trikafta to move up the OFI List, Pharmac has advised that
this will not happen before December
2022
.

“In the meantime, those who can will
make the decision to leave NZ, their home, families,
education, and careers to access Trikafta or another CFTR
modulator overseas. Others will desperately seek access to
Trikafta by any means they can or try to access unregulated
alternatives, potentially putting their health at further
risk while simply trying to stay alive,” said
Lisa.

New Zealand’s current medicines funding system
is out of step with the rest of the world, cost focused and
obsessed with procuring cheap drugs at the expense of health
outcomes. The perception that the Pharmac model is the envy
of other countries, is simply not true, it’s an example of
what not to do and their model hasn’t been adopted
anywhere else in the world.

“This game of chance,
playing with the lives of our CF community is unacceptable.
We need a medicines framework that recognises funding
medicines like Trikafta is an investment in the people of
New Zealand and our health system. Until we do, thousands of
sick and vulnerable Kiwis will continue to experience
needless suffering and early death.”

“CFNZ and our
CF community remains relentless in our determination to get
Trikafta funded in New Zealand. Kiwis deserve better
than this, HOPE shouldn’t be our only option for a
medicine’s
strategy
.”

© Scoop Media

Join Scoop Citizen

Scoop is a champion of independent journalism and open publishing – informing New Zealanders through straight-talking independent journalism, and publishing news from a wide range of sectors. Join us and support the publication of trustworthy, relevant, public interest news, freely accessible to all New Zealanders:

Become a member
Find out more

 



Source link

ShareTweetSend
Previous Post

Kate Beckinsale, 49, wows in pink gown and black latex gloves at film festival

Next Post

Gov’t to subsidise electricity bills through December

Related News

Te Whāriki Research Journey: From New Mexico to Rarotonga and Back to INIHKD
New Zealand

Te Whāriki Research Journey: From New Mexico to Rarotonga and Back to INIHKD

November 15, 2026
KBR Collaborative Media Agency Joins Forces with AIMA for Enhanced Industry Impact
New Zealand

KBR Collaborative Media Agency Joins Forces with AIMA for Enhanced Industry Impact

November 15, 2026
Wales Ends 73-Year Wait with Stunning Victory Over All Blacks in Cardiff
New Zealand

Wales Ends 73-Year Wait with Stunning Victory Over All Blacks in Cardiff

November 14, 2026
Exploring the Paradox: The Dual Nature of Safety Risks in Materials
New Zealand

Exploring the Paradox: The Dual Nature of Safety Risks in Materials

November 14, 2026
Next Post
Gov’t to subsidise electricity bills through December

Gov’t to subsidise electricity bills through December

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Gators Shock Wildcats 21-14 in Thrilling Upset Amid Rollercoaster Season

      Gators Shock Wildcats 21-14 in Thrilling Upset Amid Rollercoaster Season

      November 15, 2026
      Government Announces Historic  Billion Investment in Energy Infrastructure Development

      Government Announces Historic $2 Billion Investment in Energy Infrastructure Development

      November 15, 2026
      Notre Dame Postgame Insights: Dive into Superchats with Westwood One Sports

      Notre Dame Postgame Insights: Dive into Superchats with Westwood One Sports

      November 15, 2026
      Transform Your Laptop Setup with These 5 Affordable Accessories

      Transform Your Laptop Setup with These 5 Affordable Accessories

      November 15, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy